Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
Top Cited Papers
Open Access
- 14 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 110 (3), 551-555
- https://doi.org/10.1038/bjc.2013.725
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer DrugsJournal of Clinical Oncology, 2012
- Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon CancerJNCI Journal of the National Cancer Institute, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Abiraterone and Increased Survival in Metastatic Prostate CancerThe New England Journal of Medicine, 2011
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast CancerJournal of Clinical Oncology, 2011
- The impact of audit and feedback on nodal harvest in colorectal cancerBMC Cancer, 2011
- Adoption of Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Population-Based Outcomes StudyJournal of Clinical Oncology, 2010
- Evolution of the Randomized Controlled Trial in Oncology Over Three DecadesJournal of Clinical Oncology, 2008
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- More Extensive Nodal Dissection Improves Survival for Stages I to III of Colon CancerTransactions of the ... Meeting of the American Surgical Association, 2006